Effects of nitric oxide on neointima formation after balloon arterial injury.

一氧化氮对球囊动脉损伤后新内膜形成的影响。

基本信息

  • 批准号:
    06670734
  • 负责人:
  • 金额:
    $ 1.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

We investigated the effect of nitric oxide (NO) on neointima formatin after balloon injury in rat carotid artery. Moreoverwe investigated the antiproliferative effect of L-Arginine (LARG,precursor of NO) and enalapril (ACE in hibitor) which was thought to stimulate NO formation via inhibition of kinin degradation. L-arginine, the same dose of D-arginine (DARG), L-NAME (inhibitor of NOS,NO syntase) or saline was administered intravenously to 12-week-old SD rats using osmotic pump during 14 days after balloon injury in rat carotid artery. Enalapril (orally), LARG and enalapril was administerd according to the same protocol. Then, these animals were sacrificed and perfusion fixed at pressure of 100 mmHg with 10% formaline. Serial cross sections were prepared from representative injured carotid artery. Area ratio of intima to media (I/M) was evaluated histopathologically. The I/M in the LARG group was lower than saline or DARG group, but that in L-NAME group was not higher than saline group. It suggested that endogeneous NO had not enough antiproliferative effect on the neointima although LARG had enough effect on that via NO production. Moreover the I/M in the combination of LARG and enalapril was lower than LARG or enalapril alone. In addition, immunostaining for inducible NOS was performed to each. Expression of inducible NOS in enalapril alone and combination of LARG and enalapril were much stronger than other group. These findings suggest that the combination of LARG and enalapril has much more powerfull antiproriferative effects on the neointima than LARG or enalapril alone and it was partly due to inducible NOS upregulation by enalapril.
本实验观察了一氧化氮(NO)在大鼠颈动脉球囊损伤后新生内膜形成中的作用。此外,我们研究了L-精氨酸(LARG,NO的前体)和依那普利(ACE抑制剂)的抗增殖作用,依那普利被认为通过抑制激肽降解来刺激NO的形成。12周龄SD大鼠颈总动脉球囊损伤后14 d内,用渗透泵分别静脉注射L-精氨酸、等剂量D-精氨酸(DARG)、L-NAME(NOS抑制剂,NO syntase)或生理盐水。依那普利(口服)、LARG和依那普利按相同方案给药。然后,将这些动物处死,并用10%福尔马林在100 mmHg的压力下灌注固定。从代表性损伤的颈动脉制备连续横截面。组织病理学观察内膜与中膜面积比(I/M)。LARG组的I/M值低于生理盐水组和DARG组,而L-NAME组的I/M值不高于生理盐水组。说明内源性NO对新生内膜的抗增殖作用不明显,LARG通过NO的产生对新生内膜的抗增殖作用较强。此外,LARG和依那普利组合的I/M低于LARG或依那普利单独。此外,对每种进行诱导型NOS的免疫染色。依那普利单用及LARG与依那普利合用组诱导型NOS的表达明显强于其他组。这些结果表明,LARG和依那普利的组合有更强大的抗增殖作用的新生内膜比LARG或依那普利单独,这是部分由于诱导型NOS上调依那普利。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takayuki Ohwada, Joji Shindo, Tomiyoshi Saito, Kazuhira Maehara Yukio Maruyama: "Effects of L-arginine and Enalapril on Neointima Formation after Balloon Arterial Injury" Jpn.Circ.J. Vol.60 Supple.I. 290 (1996)
Takayuki Ohwada、Joji Shindo、Tomiyoshi Saito、Kazuhira Maehara Yukio Maruyama:“L-精氨酸和依那普利对球囊动脉损伤后新内膜形成的影响”Jpn.Circ.J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大和田尊之・新道譲二・斎藤富善・前原和平・丸山幸夫: "傷害血管内膜肥厚に対するNitric Oxideの作用およびL-arginineとEnalaprilの併用効果" Japanese Circulation Journal. Vol. 60Suppl I. 290 (1996)
Takayuki Owada、Joji Shindo、Tomiyoshi Saito、Kazuhei Maehara 和 Yukio Maruyama:“一氧化氮对受损血管内膜增厚的影响以及 L-精氨酸和依那普利的联合作用”日本循环杂志第 60 卷增刊 I. 290。 ) )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARUYAMA Yukio其他文献

MARUYAMA Yukio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARUYAMA Yukio', 18)}}的其他基金

Signaling pathway and therapeutic strategy of endothelial dysfunction : role of small GTP-binding protein RhoA and beneficial effects of HMG-CoA reductase inhibitor
内皮功能障碍的信号通路和治疗策略:小GTP结合蛋白RhoA的作用和HMG-CoA还原酶抑制剂的有益作用
  • 批准号:
    14370232
  • 财政年份:
    2002
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Therapeutic strategies for coronary stenosis-induced cardiac dysfunction and remodeling
冠状动脉狭窄引起的心功能障碍和重构的治疗策略
  • 批准号:
    11670696
  • 财政年份:
    1999
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The collection and analysis of map data of the reclamation in the lower basin of Yoshino-gawa river in the ancient Awa-koku province
古阿波国吉野川下游流域围垦地图数据的收集与分析
  • 批准号:
    07451077
  • 财政年份:
    1995
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Cyclin-dependent kinase (CDK)19-mediated vein graft intimal hyperplasia
细胞周期蛋白依赖性激酶(CDK)19介导的静脉移植内膜增生
  • 批准号:
    10664327
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
In vivo vascular delivery of an MK2 inhibitory peptide for the prevention of smooth muscle cell phenotype switch and intimal hyperplasia.
MK2 抑制肽的体内血管递送可预防平滑肌细胞表型转换和内膜增生。
  • 批准号:
    10729846
  • 财政年份:
    2022
  • 资助金额:
    $ 1.22万
  • 项目类别:
Prevention of progressive intimal hyperplasia (IH) of vein graft in pig model by suppression of IH related genes detected in clinical specimens.
通过抑制临床标本中检测到的 IH 相关基因来预防猪模型静脉移植物进行性内膜增生 (IH)。
  • 批准号:
    21H03013
  • 财政年份:
    2021
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
BET Bromodomain proteins as Novel Epigenetic Targets for prevention of Intimal Hyperplasia after Vascular Surgery
BET 溴结构域蛋白作为预防血管手术后内膜增生的新表观遗传靶点
  • 批准号:
    10298010
  • 财政年份:
    2020
  • 资助金额:
    $ 1.22万
  • 项目类别:
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction
开发单分子纳米粒子介导的外膜周围药物递送系统,用于持续和靶向抑制开放血管重建后的内膜增生
  • 批准号:
    10305283
  • 财政年份:
    2020
  • 资助金额:
    $ 1.22万
  • 项目类别:
The Role of the Thrombospondins in Intimal Hyperplasia
血小板反应蛋白在内膜增生中的作用
  • 批准号:
    10044162
  • 财政年份:
    2019
  • 资助金额:
    $ 1.22万
  • 项目类别:
Corrosion Fatigue Resistant and Intimal Hyperplasia Suppressive Biometal for Bioabsorbable Stents
用于生物可吸收支架的抗腐蚀疲劳和内膜增生抑制生物金属
  • 批准号:
    9816239
  • 财政年份:
    2019
  • 资助金额:
    $ 1.22万
  • 项目类别:
Corrosion Fatigue Resistant and Intimal Hyperplasia Suppressive Biometal for Bioabsorbable Stents
用于生物可吸收支架的抗腐蚀疲劳和内膜增生抑制生物金属
  • 批准号:
    10183308
  • 财政年份:
    2019
  • 资助金额:
    $ 1.22万
  • 项目类别:
Development of FIR therapy for suppressing vascular intimal hyperplasia
抑制血管内膜增生的远红外线疗法的开发
  • 批准号:
    19K09259
  • 财政年份:
    2019
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and elucidating of function of cells involved with intimal hyperplasia in a valve site of vein graft
静脉移植瓣膜部位内膜增生相关细胞的鉴定和功能阐明
  • 批准号:
    18K16380
  • 财政年份:
    2018
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了